Buscar
Mostrando ítems 1-10 de 68
Glargine vs. NPH insulin therapy in pregnancies complicated by diabetes: An observational cohort study
(Elsevier B.V., 2010-07-01)
Aims: The effects of glargine insulin therapy in pregnancies are not well established. We compared maternal and neonatal outcomes of women with pregestational and gestational diabetes treated with glargine or NPH ...
Glargine vs. NPH insulin therapy in pregnancies complicated by diabetes: An observational cohort study
(Elsevier B.V., 2010-07-01)
Aims: The effects of glargine insulin therapy in pregnancies are not well established. We compared maternal and neonatal outcomes of women with pregestational and gestational diabetes treated with glargine or NPH ...
Degludec: The New Ultra-long Insulin Analogue
(BIOMED CENTRAL LTDLONDON, 2015)
Insulin analogues in the treatment of diabetes in pregnancyAnálogos de insulina no tratamento do diabetes gestacional
(Sociedade Brasileira de Endocrinologia e Metabologia, 2012)
Pregnancy affects both maternal and fetal metabolism, and even in non-diabetic women, it exerts a diabetogenic effect. Among pregnant women, 2% to 14% develop gestational diabetes. Pregnancy can also occur in women with ...
Comparison of pharmacodynamics and pharmacokinetics of insulin degludec and insulin glargine 300 U/mL in healthy cats
(2019-10-01)
Insulin glargine 300 U/mL (IGla-U300) and insulin degludec (IDeg) are synthetic insulin analogs designed as basal insulin formulations. In people, IGla-U300 is more predictable and longer acting compared with glargine 100 ...
Diabetes and pregnancy: An update of the problem
(2007-12-01)
Pregnancies complicated by diabetes account for about 7% of all pregnancies attended by the Brazilian Unified Healthcare System (SUS) and are one of the main causes of maternal/perinatal morbidity and mortality in Brazil. ...
Diabetes and pregnancy: An update of the problem
(2007-12-01)
Pregnancies complicated by diabetes account for about 7% of all pregnancies attended by the Brazilian Unified Healthcare System (SUS) and are one of the main causes of maternal/perinatal morbidity and mortality in Brazil. ...